According to the Centers for Disease Control and Prevention, 30-60% of patients infected with this fungus died, but many had co-existing conditions that increased the risk of death.
Candida auris is becoming more and more harmful because of the increasing rate of infections recorded by the CDC
, that is, it cannot be treated with standard antifungal drugs. The frequency of Candida auris cases resistant to standard therapy for the infection has tripled in 2021, according to data.
According to a recent CDC report, the fungus has been found in half of the 50 states and is on the rise across the United States. However, not all states face the same level of threat. Some places, such as Washington and Maine, were virtually spared, while others, such as California and Illinois, saw an increase in new cases. The CDC has released several maps showing which states require the most attention.
With 384 clinical cases last year, Nevada has the highest number of Candida auris infections of any state in 2022. Since the symptoms of Candida auris infection – fever and chills – can be explained by a co-occurring disease, it requires a special laboratory test. confirm the diagnosis.
In 2022, California, Florida, and New York had the highest rates of Candida auris infections, in that order. Candida auris has been on the radar of US health officials since 2013 after the fungus infected small numbers of people in Illinois, New York and New Jersey. Since then, New York and Illinois have had the highest cases of Candida auris in the country. Because these states have been dealing with the fungus longer, health officials in these states may be better prepared to detect and identify it.
This map depicts the total number of Candida auris infections reported in the United States over the past ten years. Since 2013, 5,654 clinical cases of the disease have been reported in the United States.